Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
Ureteral Obstruction
About this trial
This is an interventional treatment trial for Ureteral Obstruction focused on measuring Extrinsic ureteral obstruction, Memokath 051 Ureteral Stent, JJ Stent, Stent
Eligibility Criteria
Inclusion Criteria: Presence of extrinsic ureteral obstruction secondary to inoperable pelvic or abdominal malignancy or secondary to changes caused by surgery, chemotherapy, or radiation for pelvic and/or abdominal malignancies who have had >2 standard double J stent exchanges with no prospect of being stent-free Life expectancy greater than 4 months Adult patient (18 years of age or older) Preoperative medical examination clearing the patient for general anesthesia No active urinary tract infection by urinalysis and urine culture. Exclusion Criteria: Ureteral obstruction of a benign or intrinsic etiology Lower urinary tract abnormality precluding cystoscopic stent placement Patients with a solitary kidney Patients not willing or unable to receive their post-operative follow-up at the Mayo Clinic in Rochester, Minnesota Pregnant female patient.
Sites / Locations
- Mayo Clinic
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Memokath 051 Ureteral Stent
JJ Stent
Subjects assigned to this arm received a Memokath 051 Ureteral Stent.
Subjects assigned to this arm received a JJ stent.